Roche's Tecentriq OK'd in Canada for first-line lung cancer - Seeking Alpha

Roche's Tecentriq OK'd in Canada for first-line lung cancer  Seeking Alpha

Health Canada approves Roche's (RHHBY) Tecentriq (atezolizumab), combined with Avastin (bevacizumab), paclitaxel and carboplatin, for the first-line treatm.